margin 25.3% 18.1% Net profit margin 17.6% 11.9% Debt to Equity ratio 0.17 0.10 Earnings per share 0.66 0.46 ROA 13.1% 11.0% ROE 14.0% 10.9% Gross profit margin = Gross Profit (Total Sales – Costs of Sales
Profit - attributable to equity holders of the parent 14.56 24.26 (9.70) (39.98) Gross Profit Margin (%) 24.51 27.10 Net Profit Margin (%) 6.70 9.88 Unit: million Baht For 6-month period (Jan-Jun) 2020
- attributable to equity holders of the parent 24.15 30.57 (6.42) (21.00) Gross Profit Margin (%) 25.20 30.30 Net Profit Margin (%) 9.60 12.30 Unit: million Baht For 9-month period (Jan-Sep) 2019 2018 Change
in the gross profit margin that expanded from 15.3% in the third quarter of 2018 to 16.4% in the third quarter of 2019 and more efficient cost management that caused selling and administrative expense
THB 40.7 million or 24.9% and gross profit margin to total revenues was at 15.0%. The Group reported total net profit for the year 2017 at THB 50.4 million, decreased by THB 32.9 million or 39.5% when
เช่น พันธบัตร หุ้นกู้ ตั๋วสัญญาใช้เงิน บัตรเงินฝาก Letter of Credit และ Letter of Guarantee เป็นต้น 3. เงินให้กู้ยืมคงค้าง (margin loan) จำนวนเงินที่ลูกค้ากู้ยืมจากบริษัทหลักทรัพย์เพื่อซื้อหลักทรัพย์ 4
same period of 2017, due to the increasing of the quantity of Sales by 17%. 2. Cost of goods sold was Baht 1,275.68 million which the gross profit margin was decreased to 10.06% when compare to the same
115.40% Gross profit margin 61.51% 59.98% 1.53% Net profit margin 45.50% 36.59% 8.91% บริษัท ดโีอด ีไบโอเทค จ ำกดั (มหำชน) 111 หมู่ที่ 2 ต ำบลท่ำจีน อ ำเภอเมืองสมุทรสำคร จังหวดัสมุทรสำคร 74000 111 Moo 2
THB 13.4 million or 10.9% and gross profit margin to total revenues was at 15.4%. The Group reported total net profit for the year 2018 at THB 20.6 million, decreased by THB 29.8 million or 59.1% when